This article was written by Follow Equity Research Analyst at DM Martins Research.I cover stocks that are often undercovered, focusing primarily on…
PTL ETF: Inspire's Faith-Based Screens Come At A Quality Cost (NYSEARCA:PTL)
By Press Room
1 Mins read
This article was written by Follow The Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background,…
By Patrick O’Connell, CFA | John Huang, CFA | Erin Bigley, CFA The materiality of ESG factors differs across sectors and markets….
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds…
This article was written by Follow The Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background,…
Unlock the White House Watch newsletter for free Your guide to what Trump’s second term means for Washington, business and the world…
Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondroplasia Transcript
By Press Room
1 Mins read
Follow Play Earnings CallPlay Earnings Call Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and…
GPIQ Is A 'Buy,' JEPQ A 'Hold': Choosing Efficiency For The 2026 Tech Rally (NASDAQ:GPIQ)
By Press Room
1 Mins read
This article was written by Follow My professional journey in the investment field began in 2011. Today, I combine the roles of…
Operator Ladies and gentlemen, thank you for joining us, and welcome to the Penguin Solutions First Quarter Fiscal Year 2026 Financial Results…
From Trump to trade, FX to Brexit, ING’s global economists have it covered. Go to ING.com/THINK to stay a step ahead. We’re…